Probing into Causes and Formation Patterns of Drugmakers' Implementing Strategic Alliances

Xu Aijun,Chen chuanming
2005-01-01
Abstract:With the deepening of opening up to the outside world of pharmaceutical industry and the demand by SFDA that drugs manufacturing enterprises must accord with the regulation of GMP before the end of 2004, the operational environment of drugmakers has changed a lot and the imbalance of drug supply and demand becomes serious.Corporate MA strategy has gradually exposed its management risks and financial risks. As a method to exploit economies of scale or economies of scope, strategic alliance becomes another choice of drugmakers' gaining competitive advantage. Then this paper analyzes the causes why drugmakers should implement the alliance strategy and probes into all possible formation patterns of strategic alliance in the end.
What problem does this paper attempt to address?